Search Results for:"Car-T Treatment"
On-site Manufacture of CAR-T Cells Enables Faster Effective Treatments
Study explores the benefits of treating patients with CAR-T cell therapeutics manufactured on-site, as opposed to using commercially manufactured products.
Innovative hemato-oncological treatments
New studies indicate the high efficacy of novel immunotherapies, now available at Sheba, for patients with relapsed or refractory hematological malignancies.
6th COMy Congress 2020: New Treatments for Blood Cancer
The 6th World Congress on Controversies in Multiple Myeloma (COMy) was held virtually during the first week of October 2020.
After Previous Treatments Had Failed – CAR T-Cell Therapy Saved Pedro da Silva’s Life
In 2013, Pedro da Silva received intensive chemotherapy treatment for testicular cancer. In 2016, he was diagnosed with leukemia.
CAR T-Cell Leukemia Treatment Was Recently Recommended for FDA Approval
Chest pain is one of the most obvious heart attack symptoms. However, chest pain can also be a sign of less serious medical problems. This is why rapid discernment of chest pain is so critical.
Successful treatment of childhood leukemia with CAR T-cells
In a first in Israel, Sheba Medical Center has achieved remission in a pediatric patient’s leukemia through CAR T-cell therapy. This innovative therapy is still only in clinical trials in the US, but has shown excellent results in over 70% of patients. Sheba is proud to be able to offer this effective treatment to our patients.
World Cancer Day: Sheba’s Dedication to Cancer Care
February 4th marks World Cancer Day, a day of global observance and, most importantly, a golden opportunity to raise awareness of this deadly and multifaceted disease. Every year, various types of cancer are responsible for causing millions of deaths irrespective of race, age or gender. The fight against cancer is not a battle that should […]
FAQ: What are the advantages of allogeneic CAR T-cells?
Allogeneic CAR T-cells are derived from a healthy donor’s T-cells rather than the patient’s own cells, which offers several advantages. One key benefit is that allogeneic CAR T-cells can be manufactured in large quantities and stored for off-the-shelf use. This potentially reduces the time required for treatment and can be readily available for patients. Additionally, […]
FAQ: What are CAR T-cells used for?
CAR T-cells are primarily used for the treatment of certain types of blood cancers, particularly leukemia and lymphoma. They have shown remarkable success in treating relapsed or refractory cases of acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL), among others. Ongoing research aims to explore the potential use of CAR T-cells for other types of […]